BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6424637)

  • 1. [Morphogenesis of chronic granulomatous inflammation in relation to the variability of the biological properties of the causative agent].
    Kononov AV; Zinov'ev AS
    Arkh Patol; 1984; 46(2):57-63. PubMed ID: 6424637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of Brucella abortus in the livers of T cell-deficient nude mice.
    Cheville NF; Kunkle RA; Jensen AE; Palmer MV
    Lab Invest; 1995 Jul; 73(1):96-102. PubMed ID: 7603046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cell-mediated immune responses and bacterial clearance in 6-10 months old water buffalo (Bubalus bubalis) experimentally vaccinated with four dosages of commercial Brucella abortus strain RB51 vaccine.
    Diptee MD; Adesiyun AA; Asgarali Z; Campbell M; Fosgate GT
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):209-20. PubMed ID: 15963819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of simultaneous inoculation of B. abortus strain 19 and foot-and-mouth disease vaccines on immunity against brucellosis in the guinea pig].
    García-Carrillo C
    Rev Asoc Argent Microbiol; 1978; 10(1):1-7. PubMed ID: 210482
    [No Abstract]   [Full Text] [Related]  

  • 5. [Electron microscopic study of the morphology of Brucella and of the mechanism of their phagocytosis by blood cells].
    Maruashvili GM; Baramidze IV; Tsagareli ZG
    Arkh Patol; 1980; 42(8):70-5. PubMed ID: 7406724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Persistence of brucellosis L cultures in the body of an experimental animal and the duration of immunity].
    Vershilova PA; Grekova NA; Tolmacheva TA
    Vestn Akad Med Nauk SSSR; 1985; (3):10-3. PubMed ID: 3922151
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of three Brucella abortus cell-wall antigens protective in murine experimental brucellosis.
    Dubray G; Bézard G
    Ann Rech Vet; 1980; 11(4):367-73. PubMed ID: 6802061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune response of guinea pigs to combined action of brucella vaccine and homologous lysed antigen].
    Rementsova MM; Shin NG; Usmanova FI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Mar; (3):72-5. PubMed ID: 6774529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mycobacterial granulomas in guinea-pig lymph nodes.
    Narayanan RB; Badenoch-Jones P; Curtis J; Turk JL
    J Pathol; 1982 Nov; 138(3):219-33. PubMed ID: 6752360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indices of phagocytosis of S and R forms of Brucella in patients with acute and chronic brucellosis caused by Brucella abortus].
    Bukin VN
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Dec; (12):88-91. PubMed ID: 3103351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunobiological characteristics of Brucella outer membrane proteins, genetic determinants of which are expressed in Escherichia coli cells].
    Seliutina DF; Malikov VE; Chibisova VA; Gorelov VN; Skavronskaia AG
    Mol Gen Mikrobiol Virusol; 1993; (1):17-20. PubMed ID: 8510678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic responses, biosafety and clearance of four dosages of Brucella abortus strain RB51 in 6-10 months old water buffalo (Bubalus bubalis).
    Diptee MD; Adesiyun AA; Asgarali Z; Campbell M; Adone R
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):43-55. PubMed ID: 16112746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental mycobacterial granulomas in guinea pig lymph nodes: ultrastructural observations.
    Narayanan RB; Badenoch-Jones P; Turk JL
    J Pathol; 1981 Aug; 134(4):253-65. PubMed ID: 7033491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of an immunogenic fraction from Brucella abortus 45/20.
    Corbel MJ; Redwood DW
    Dev Biol Stand; 1984; 56():159-68. PubMed ID: 6436092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serologic responses, lymphocyte proliferative responses, and clearance from lymphatic organs after vaccination of bison with Brucella abortus strain RB51.
    Olsen SC; Jensen AE; Palmer MV; Stevens MG
    Am J Vet Res; 1998 Apr; 59(4):410-5. PubMed ID: 9563622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new morphological concept and classification of granulomatous inflammation: the polar granulomas.
    Michalany J; Michalany NS
    Ann Pathol; 1984; 4(2):85-95. PubMed ID: 6375689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-exposure serological and bacteriological responses of water buffalo (Bubalus bubalis) to Brucella abortus biovar 1 following vaccination with Brucella abortus strain RB51.
    Diptee MD; Asgarali Z; Campbell M; Fosgate G; Adesiyun AA
    Rev Sci Tech; 2007 Dec; 26(3):669-78. PubMed ID: 18293615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle.
    Palmer MV; Olsen SC; Cheville NF
    Am J Vet Res; 1997 May; 58(5):472-7. PubMed ID: 9140553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The origin, morphology, and function of epithelioid cells.
    Turk JL; Narayanan RB
    Immunobiology; 1982 Apr; 161(3-4):274-82. PubMed ID: 7047374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.